Bios Fund II, LP

Track

Insider profile

Bios Fund II, LP's trades of Lantern Pharma Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
358.34
Quantity 38,353
Value US$3,697,764
Transaction date
Proposed sale
Price
264.17
Quantity 58,937
Value US$1,165,737
Transaction date
Proposed sale
Price
280.08
Quantity 72,870
Value US$3,593,572
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-27 2025-05-27
PrS Proposed sale
38,353
358.34
US$3,697,764 		38,353 358.34 US$3,697,764
2024-04-26 2024-04-29
PrS Proposed sale
58,937
264.17
US$1,165,737 		58,937 264.17 US$1,165,737
2024-02-28 2024-02-27
PrS Proposed sale
72,870
280.08
US$3,593,572 		72,870 280.08 US$3,593,572